One-year recurrence rate of Graves ophthalmopathy presenting as diplopia in the primary position after varied doses of intravenous methylprednisolone followed by oral prednisolone with dosing based on the magnetic resonance imaging findings
One-year recurrence rate of Graves ophthalmopathy presenting as diplopia in the primary position after varied doses of intravenous methylprednisolone followed by oral prednisolone with dosing based on the magnetic resonance imaging findings
复制标题
根据磁共振成像结果,静脉注射不同剂量的甲基泼尼松龙,然后口服泼尼松龙后,表现为原发性复视的 Graves 眼病的一年复发率
DOI:
10.1007/s10384-022-00954-9
复制
发表时间:
2022
影响因子:
2.4
通讯作者:
Fukuchi Takeo
中科院分区:
文献类型:
--
作者:
Ueki Satoshi;Hasegawa Yukari;Hatase Tetsuhisa;Kiyokawa Megumi;Fukuchi Takeo
PurposeTo reveal the recurrence rate of Graves ophthalmopathy (GO) presenting as diplopia in the primary position for 1 year after varied doses of intravenous methylprednisolone (IVMP) followed by oral prednisolone, with dosing based on the magnetic resonance imaging (MRI) findings.Study designRetrospective study.MethodsWe analyzed the medical charts of 25 patients who were diagnosed with new-onset GO and who received treatment for diplopia in the primary position at our hospital. Treatment consisted of MRI-determined varied doses of IVMP followed by oral prednisolone. If the MRI findings showed deterioration or were unchanged after 6 g of IVMP, 3 g of IVMP was added for further treatment. Simple and multiple linear regression analyses were performed to reveal the associations between the independent variables and the dependent variable, defined as recurrence.ResultsThe mean patient age (± standard deviation) was 61.3 ± 11.3 years. The female to male ratio was 15:10. Twenty-one of the 25 patients received a total of 6 g of IVMP, whilst the remaining 4 patients received a total of 9 g of IVMP. In 5 patients (20%), the GO recurred within 1 year of IVMP administration. Simple and multiple linear regression analyses showed that the MRI findings after 6 g of IVMP affected recurrence (P< .05).ConclusionThis study showed that in 20% of patients, GO recurred within 1 year of administration of varied doses of IVMP, with the dosing based on the MRI findings. Furthermore, assessment of inflammation by use of MRI after 6 g of IVMP has a potential role in predicting recurrence.
影响因子:
39.2
作者:
Bartalena, L;Marcocci, C;Pinchera, A
通讯作者:
Pinchera, A